Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
Main Filters
Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
| BIO-RAD LABORATORIES, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 29400 | 0 | - | ||
| 29401 | 0 | - | ||
| DIAMEDIX CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 720-440 | 0 | - | ||
| 720-450 | 0 | - | ||
| DRG Instruments Gesellschaft mit beschränkter Haftung | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| EIA-2777 | 0 | - | ||
| EIA-2778 | 0 | - | ||
| EUROIMMUN Medizinische Labordiagnostika AG | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| FA 1201-12010-32 | 0 | - | ||
| HYCOR BIOMEDICAL LLC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| FGA11 | 0 | - | ||
| FGA12 | 0 | - | ||
| IMMCO DIAGNOSTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1116 | 0 | - | ||
| 1140 | 0 | - | ||
| 1140-2 | 0 | - | ||
| 1140-250 | 0 | - | ||
| 1140-250X | 0 | - | ||
| 1140-2X | 0 | - | ||
| 1140X | 0 | - | ||
| 1141 | 0 | - | ||
| 1141X | 0 | - | ||
| 1142 | 0 | - | ||
| 1142X | 0 | - | ||
| 116X | 0 | - | ||
| 2100 | 0 | - | ||
| 2100X | 0 | - | ||
| 2162 | 0 | - | ||
| 2162-10 | 0 | - | ||
| 2162-12 | 0 | - | ||
| 2186 | 0 | - | ||
| 2189 | 0 | - | ||
| 2200 | 0 | - | ||
| 2240 | 0 | - | ||
| 2252 | 0 | - | ||
| 2301 | 0 | - | ||
| 2302 | 0 | - | ||
| 2308-1 | 0 | - | ||
| 2316 | 0 | - | ||
| 2500 | 0 | - | ||
| 2505 | 0 | - | ||
| 2506 | 0 | - | ||
| 2510 | 0 | - | ||
| 2514 | 0 | - | ||
| 5160 | 0 | - | ||
| 5161 | 0 | - | ||
| 5162 | 0 | - | ||
| 5308 | 0 | - | ||
| INOVA DIAGNOSTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 701130 | 0 | - | ||
| SCIMEDX CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| A006 | 0 | - | ||
| A006P | 0 | - | ||
| A060L | 0 | - | ||
| A060PL | 0 | - | ||
| A120L | 0 | - | ||
208 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
IMMCO DIAGNOSTICS
IMMCO DIAGNOSTICS, INC.
COMVI Anti-Neutrophil Cytoplasmic Antibody (c+pANCA) IFA Kit
0
-
IMMCO DIAGNOSTICS
IMMCO DIAGNOSTICS, INC.
Anti-neutrophil Cytoplasmic Antibody (ANCA) IFA Kit
0
-
IMMCO DIAGNOSTICS
IMMCO DIAGNOSTICS, INC.
Anti-neutrophil Cytoplasmic Antibody (ANCA) IFA Kit
0
-
IMMCO DIAGNOSTICS
IMMCO DIAGNOSTICS, INC.
Anti-neutrophil Cytoplasmic Antibody (ANCA) IFA Kit
0
-
IMMCO DIAGNOSTICS
IMMCO DIAGNOSTICS, INC.
COMVI Anti-Neutrophil Cytoplasmic Antibody (c+pANCA) IFA Kit
0
-
Autostat II Anti-MPO
HYCOR BIOMEDICAL LLC
96 well ELISA for the detection of anti-MPO antibodies in human serum
0
-
Autostat II Anti-PR 3
HYCOR BIOMEDICAL LLC
96 well ELISA for the detection of anti-PR 3 antibodies in human serum
0
-
QUANTA Flash® MPO Reagents
INOVA DIAGNOSTICS, INC.
1. QUANTA Flash MPO Reagent Cartridge contains the following reagents for 100 determinations:a. MPO coated paramagnetic beads, in a liquid containing buffer, protein stabilizers and preservative.b. Assay Buffer – colored pink, containing Tris-buffered saline, Tween 20, protein stabilizers and preservatives.c. Tracer IgG– Isoluminol labeled anti-human IgG antibodies, containing buffer, protein stabilizers and preservative.d. Sample Dilution Buffer – colored pink, containing Tris-buffered saline, Tween 20, protein stabilizers and preservatives.
0
-
Proteinase-3 IgG ELISA
DRG Instruments Gesellschaft mit beschränkter Haftung
The DRG ELISA Proteinase-3 (PR-3) Test System is intended for the qualitative and semi-quantitative detection of IgG-class antibody to proteninase-3 in human serum. The test is intended to be used as an aid in the diagnosis of various autoimmune vasculitic disorders characterized by elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA).
0
-
ANCA Screen IgG ELISA
DRG Instruments Gesellschaft mit beschränkter Haftung
The ANCA Screen ELISA test system is intended for the qualitative detection of anti-Myeloperoxidase and/or anti-Proteinase-3 IgG antibody in human serum. The test system is intended to be used as an aid in the diagnosis of various autoimmune vasculitic disorders characterized by elevated levels of anti-neutrophil cytoplasmic antibodies (ANCA).
